Table: begin end state 1 1632 non-cytoplasmic
Input: >PfGW456L13_3298 MAFFTAASKADFQHQLQAALAQHISEQALPQVALFSEQFFGIISLDELTQRRLSDLAGCT LSAWRMLERFDHAQPQVRVYNPDYERHGWQSTHTAVEVLHHDLPFLVDSVRTELNRRGYS IHTLQTTVLSVRRGSKGELLEILPKGTQGDDIQQESLMYLEIDRCANTAELNVLSKELEQ VLGEVRVAVGDFEPMKAKVQDILTKLDNSQFAVDGDEKNEIKSFLEWLVGNHFTFLGYEE FVVSDEADGGHIVYDKDSFLGLTKLLRAGLTYDDLRIEDYAVNYLREPTLLSFAKAAHPS RVHRPAYPDYVSIREIDADGKVIKECRFMGLYTSSVYGESVRVIPYIRRKVEEIERRSGF QAKAHLGKELAQVLEVLPRDDLFQTPVDELFSTVMSIVQIQERNKIRVFLRKDPYGRFCY CLAYVPRDIYSTEVRQKIQQVLMDRLKASDCEFWTFFSESVLARVQLILRVDPKNRLDID PLLLEKEVVQACRSWQDDYAALTVESFGEAHGTNVLADFPKGFPAGYRERFAAHSAVVDM QHLLSLNEKNPLVMSFYQPLGQVSGQRMLHCKLYHADTPLALSDVLPILENLGLRVLGEF PYRLRHNSGREFWIHDFAFTAAEGLELDIQQLNDTLQDAFVHIVRGDAENDGFNRLVLTA GLPWRDVALLRAYARYMKQIRLGFDLGYIASTLNNHTDIAHELTRLFKTRFYLARKLTGE DLGDKQQRLEHAILSALDDVQVLNEDRILRRYLDLIKATLRTNFYQTDANGHNKSYFSFK FNPHLIPELPKPVPKFEIFVYSPRVEGVHLRFGNVARGGLRWSDREEDFRTEVLGLVKAQ QVKNSVIVPVGAKGGFLPRRLPLGGSRDEIAAEGIACYRIFISGLLDITDNLKDGALVPP ANVVRHDDDDPYLVVAADKGTATFSDIANGIAIDYGFWLGDAFASGGSAGYDHKKMGITA KGAWVGVQRHFRERGINVQEDSITVVGVGDMAGDVFGNGLLMSDKLQLVAAFNHLHIFID PNPEPASSFAERQRLFDLPRSAWSDYDTSLMSEGGGIFSRSAKSIAISPQMQERFDIQAD KLTPTELLNALLKAPVDLLWNGGIGTYVKASSESHADVGDKANDALRVNGNELRCKVVGE GGNLGMTQLGRVEFGLNGGGSNTDFIDNAGGVDCSDHEVNIKILLNEVVQAGDMTDKQRN ELLASMTDEVGGLVLGNNYKQTQALSLAARRALPRIAEYKRLMNDLEGRGKLDRAIEFLP AEEAINERIAEGHGLTRAELSVLISYSKIDLKEQLLGSLVPDDDYLTRDMETAFPPTLVS KFSAAMRRHRLKREIVSTQIANDLVNHMGITFVQRLKESTGMSPANVAGAYVIVRDIFHL PHWFRQIENLDYKVSADVQLELMDELMRLGRRATRWFLRARRNEQNAARDVAHFGPHLAA LGLKLDELLSGEIRETWQTRYQAYVEAGVPELLARMVAGTTHLYTLLPIIEASDVTGQDP ADVAKAYFAVGSALDITWYLQQISALPVENNWQALAREAFRDDVDWQQRAITISVLQQGD GSQEVETRLDLWMQQHESMIERWRAMLVEIRAASGTDYAMYAVANRELLDLALSGQAVVP AAVAAAELEPAA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server